Management of initial gout in adults.

GUIDELINE TITLE
Management of initial gout in adults.

BIBLIOGRAPHIC SOURCE(S)
The University of Texas at Austin, School of Nursing, Family Nurse Practitioner Program. Management of initial gout in adults. Austin (TX): University of Texas at Austin, School of Nursing; 2009 May. 9 p. [23 references]

GUIDELINE STATUS
This is the current release of the guideline.

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

July 30, 2009 - Colchicine (Colcrys): The U.S. Food and Drug Administration (FDA) notified healthcare professionals of the approval of the first single-ingredient oral colchicine product, Colcrys, for the treatment of familial Mediterranean fever (FMF) and acute gout flares and of two previously uncharacterized safety concerns associated with the use of colchicine. FDA has included important safety considerations in the approved prescribing information to assure safe use of Colcrys and is providing background information, a data summary and recommendations in this alert.

open here to see the full-text:
Management of initial gout in adults.